All treatments
Treatment
visugromab (CTL-002) clinical trials
2 indexed studies · 1 currently recruiting
- Active not recruitingPHASE1, PHASE2
First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)
This study is looking at a new drug called visugromab (CTL-002) for people with advanced cancer. It aims to see how safe the drug is, what doses work best, and if it can help fight different types of solid tumours, sometimes used with another cancer medicine.
For: Solid Tumor, AdultGermany · Spain · Switzerland - RecruitingPHASE2, PHASE3
Visugromab in Cachexia International Trial
This study looks at a new drug called visugromab for people with certain cancers and severe weight loss (cachexia). It checks if the drug helps with weight gain, appetite, and movement. Researchers also want to know about any side effects. It's compared to a dummy treatment.
For: Cancer-associated CachexiaUnited States · Bulgaria · Czechia